Résultats de recherche
Scott Gottlieb (born June 11, 1972) is an American physician, investor, and author who served as the 23rd commissioner of the Food and Drug Administration (FDA) from May 2017 until April 2019.
Scott Gottlieb, M.D. Age: 52 years. Partner, New Enterprise Associates, Inc.’s Healthcare Investment Team and Resident Fellow of the American Enterprise Institute since 2019. Served as the 23rd Commissioner of the FDA from 2017 to 2019.
6 oct. 2021 · Dr. Scott Gottlieb led the Food and Drug Administration from 2017 to 2019. His new book discusses successes and failures of the U.S. response and how to plan ahead for future pandemics.
- John Henning Schumann
21 sept. 2021 · Former FDA Commissioner Dr. Scott Gottlieb, a Pfizer board member, discusses the FDA and CDC's approval process for Pfizer's Covid boosters. He says the CDC may expand the eligibility criteria and offer more guidance on severe conditions that qualify for third doses.
21 nov. 2021 · That depends on the public health goal, said Dr. Scott Gottlieb, the former commissioner of the Food and Drug Administration. On Friday, the F.D.A. endorsed Moderna and Pfizer-BioNTech vaccine...
Dr. Scott Gottlieb served as the 23rd Commissioner of Food and Drugs from 2017 to 2019. He is a physician, medical policy expert, and public health advocate who worked on various issues such as healthcare information technology, new medical technologies, and drug coverage.
26 sept. 2021 · Former FDA commissioner and Pfizer board member Dr. Scott Gottlieb discusses the process and criteria for getting COVID-19 booster shots in the US. He criticizes the slow and deliberative approach of FDA and CDC and suggests a different process for a pandemic.
